A New Dawn for Parkinson’s Treatment: Landmark STEM-PD Trial Shows Promise in Regenerative Medicine
In a breakthrough that could fundamentally alter the trajectory of neurodegenerative disease management, a landmark Phase I/II clinical study has...
In a breakthrough that could fundamentally alter the trajectory of neurodegenerative disease management, a landmark Phase I/II clinical study has...
Acute myeloid leukemia (AML) has long been defined by its lethality. With a survival rate hovering around a sobering 29...
Despite decades of medical advancement and the widespread use of statins and PCSK9 inhibitors, cardiovascular disease (CVD) remains the leading...
Duchenne muscular dystrophy (DMD), a devastating genetic condition characterized by progressive muscle degeneration, has long remained a "holy grail" for...